Icon Bioscience begins pivotal phase II/III trial of novel ophthalmic drug IBI-10090 Jan. 8, 2010 No Comments
pSivida reports 24-month results from phase III FAME study of Iluvien for DME Dec. 29, 2009 No Comments
ThromboGenics completes enrollment in second phase III trial of microplasmin Dec. 22, 2009 No Comments
Interim data from phase I trial of Cortiject in diabetic macular edema disclosed at ISOPT Dec. 21, 2009 No Comments
RSS